ArticleVirchows Archiv : an international journal of pathology2003
Hepatoid adenocarcinoma of the urinary bladder.
Article in Virchows Archiv : an international journal of pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 80 citations in OpenAlex.
- Diagnostic challenges in a rare case of bladder metastasis from lung hepatoid adenocarcinoma: The first reported case.Urology case reports · 2026Article
- Imaging of pancreatic hepatoid adenocarcinoma: a scoping review.Quantitative imaging in medicine and surgery · 2026Review
- Case Report: Alpha-fetoprotein-producing urothelial carcinoma of the bladder.Frontiers in oncology · 2025Article
- Hepatoid adenocarcinoma in ureter with next-generation sequencing: A case report and literature review.BMC medical genomics · 2024Review
- Primary Peritoneal Hepatoid Adenocarcinoma Patients Treated by Complete Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Indian journal of surgical oncology · 2023Article
- Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature.Frontiers in oncology · 2022Article
- Primary Hepatoid Adenocarcinoma of Gallbladder With MB21D2/GALNT12/ARID2 Mutations: A Case Report.Frontiers in endocrinology · 2021Article
- Hepatoid carcinoma of the pancreas: A case report and review of the literature.World journal of clinical cases · 2020Article
- Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.Medicine · 2018Review
- Hepatoid adenocarcinoma arising from heterotopic pancreas of the ileum: A case report.Medicine · 2016Article
- Hepatoid Adenocarcinoma of the Urachus.Case reports in pathology · 2016Article
- Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature.Hepatobiliary surgery and nutrition · 2015Article
- Hepatoid carcinoma of the pancreas.World journal of surgical oncology · 2015Article
- Adenocarcinoma of the urinary bladder.American journal of clinical and experimental urology · 2015Review
- Hepatoid adenocarcinoma of the lung: a case report and review of the literature.Journal of gastrointestinal cancer · 2014Review
- A rare tumor in a patient with hepatic hydatic cyst: adrenal hepatoid adenocarcinoma.Case reports in medicine · 2014Article
- Primary hepatocellular carcinoma ("hepatoid" carcinoma) of the pancreas: a case report and review of the literature.Clinical case reports · 2013Article
- A case of alpha-fetoprotein-producing esophageal adenocarcinoma.The Kaohsiung journal of medical sciences · 2013Article
- Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.World journal of gastroenterology · 2013Review
- A 49-year-old woman presenting with hepatoid adenocarcinoma of the urinary bladder: a case report.Journal of medical case reports · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatoid adenocarcinoma is rare in the urinary bladder with only three well-illustrated previously reported cases. Pathological diagnosis is based on a combination of histological features resembling hepatocellular carcinoma and the positive immunostaining for alpha-fetoprotein. We present the clinicopathological features of four additional cases. The patients were males 66, 85, 61 and 68 years old. Hematuria was the initial symptom in all four patients. Two cases were treated by cystoprostatectomy and the remaining two by transurethral resection of the bladder. On histology, the cases showed a mixture of cells growing in a solid fashion and sheets or anastomosing trabeculae of hepatoid cells merging focally with a secondary glandular pattern of adenocarcinoma. Intracytoplasmic hyaline globules in all and bile production in three of the cases also supported the impression of hepatocytic differentiation. Immunoreactivity for alpha-fetoprotein, low molecular weight cytokeratin, alpha-1-antitrypsin, albumin, epithelial membrane antigen and a striking canalicular pattern when stained against polyclonal carcinoembryonic antigen (CEA), all indicate hepatocellular differentiation. The hepatic nature of the cells was further assessed by detecting the recently incorporated marker hepatocyte paraffin 1, by means of immunohistochemistry and albumin gene mRNA non-isotopic in situ hybridization, both of which had positive signals in all four cases. Three patients died 12, 14 and 19 months after diagnosis. The fourth patient was alive with disease at 26 months of follow-up. In conclusion, hepatoid adenocarcinoma seems to be an aggressive malignant neoplasm that is rare in the bladder whose correct diagnosis may need appropriate immunohistochemical and in situ hybridization means in addition to a complete patient clinical and pathological evaluation. The exact histogenesis and classification of these tumors remains to be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.